Target intelligence / Profile preview

Scalp vasculature (None)

Target
None
Molecular classification
Other (not a single molecule or protein family; refers to a network of blood vessels)
01

Overview

The **scalp vasculature** refers collectively to the network of arteries and veins supplying blood to the skin, connective tissue, and underlying structures covering the skull. It is not a single molecule or receptor but an anatomical system composed primarily of branches from the external carotid artery—namely, the superficial temporal artery, posterior auricular artery, occipital artery—and branches from the internal carotid via its ophthalmic branch (supratrochlear and supraorbital arteries). Venous drainage occurs through similarly named veins that ultimately drain into jugular venous systems. This extensive vascular network provides robust perfusion necessary for hair growth, thermoregulation, wound healing, and protection against infection. The dense interconnections also mean that injuries can result in significant bleeding. Certain congenital or acquired conditions can affect these vessels—such as hemangiomas or telangiectasias—but there are no known drugs designed specifically for this anatomical target. Because "scalp vasculature" is not a discrete molecular entity but rather an anatomical feature comprising many vessel types (arteries/capillaries/veins), it does **not qualify as a therapeutic target like receptors or enzymes**, nor does it have canonical abbreviations or direct drug interactions typical for molecular targets.

Other names
Vasculature of the scalpblood vessels of the scalparteries and veins of the scalp
02

Mechanism of action

Not applicable for this anatomical structure. General mechanisms include: - Vasoconstriction/vasodilation by systemic agents (e.g., local anesthetics with epinephrine for hemostasis during surgery)

03

Biological functions

Blood supply to scalp tissuesNutrient and oxygen deliveryWaste removalThermoregulationWound healing support
04

Disease associations

Vascular malformations (e.g., hemangiomas, vascular naevi)Scalp wounds/bleeding complicationsInfections spreading via emissary veinsRarely involved in systemic vascular diseases (e.g., vasculitis)
05

Safety considerations

Profuse bleeding from lacerations due to rich vascular supplyRisk of infection spread through venous connections ("danger zone" layer)
06

Interacting drugs

None specific; general vasoactive drugs may affect these vessels but there are no drugs that specifically target "scalp vasculature" as a molecular entity.
07

Biomarkers

None specific to "scalp vasculature"

Beyond the preview

Go deeper on Scalp vasculature (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scalp vasculature (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call